%20(1).png?width=204&name=Invicro_logo-WHITE%20(002)%20(1).png){kind=logo}
Recent computational advances have re-energized interest in machine learning and deep learning across a wide range of disciplines.
In this webinar, you will learn how these data-driven analytics methods are being used in support of image and data analysis across all phases of drug development.
Dr. Hesterman’s team develops novel image processing, machine learning, and modeling methods; as well as image processing tools used to extract quantitative information supporting projects spanning multiple imaging modalities and therapeutic areas.
Prior to joining Invicro, Dr. Hesterman managed Bioscan’s NanoSPECT/CT project in Budapest, Hungary, and served as a visiting scientist in the Frangioni Lab at Beth Israel Deaconess Medical Center, a Harvard Medical School Teaching Hospital.
As an interdisciplinary scientist with a focus on neuro MR, Dr. Avants has broadly explored the synergies between machine learning, brain mapping and mathematical modeling. Dr. Avants will utilize this expertise in developing computational and algorithmic advances to enhance Invicro’s imaging and data analytics platform.
Within a single platform, Pharma and biotech customers will value a robust solution that combines leading data management and domain knowledge modeling methods with state-of-the-art ML and AI tools, bolstering Invicro’s analysis solutions in oncology, neuro, pulmonary, and other therapeutic areas.